MARCOS TRUJILLO CUE: Open Payments
NPI 1619443363 · ATLANTIS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,182 in 95 payments from 19 companies in 2025. Trend: 2023 $623 · 2024 $1,299 · 2025 $2,182
Food & beverage: $2,182
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 33 | $684 |
| Eisai Inc. | 10 | $255 |
| Takeda Pharmaceuticals U.S.A., Inc. | 8 | $209 |
| Lilly USA, LLC | 10 | $187 |
| Neurelis, Inc. | 8 | $137 |
| UCB, Inc. | 4 | $133 |
| ACADIA Pharmaceuticals Inc | 1 | $115 |
| Biogen, Inc. | 4 | $80 |
| Otsuka America Pharmaceutical, Inc. | 3 | $66 |
| ARGENX US, INC. | 2 | $57 |
Products named: Leqembi, QULIPTA, UBRELVY, HYQVIA, KISUNLA, VALTOCO, BOTOX, NUPLAZID.
Industry payments across FL — which companies pay providers there.
